Cargando…
SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors
DNA methylation has been recognized as a putative regulatory mechanism for CYP11B2 in primary hyperaldosteronism. We aimed to investigate the DNA methylation and the expression of a panel of genes encoding several enzymes involved in steroidogenesis in adrenocortical benign tumors. We collected a to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552772/ http://dx.doi.org/10.1210/js.2019-SUN-044 |
_version_ | 1783424664390860800 |
---|---|
author | Di Dalmazi, Guido Morandi, Luca Rubin, Beatrice Pilon, Catia Asioli, Sofia Maffeis, Valeria Fallo, Francesco |
author_facet | Di Dalmazi, Guido Morandi, Luca Rubin, Beatrice Pilon, Catia Asioli, Sofia Maffeis, Valeria Fallo, Francesco |
author_sort | Di Dalmazi, Guido |
collection | PubMed |
description | DNA methylation has been recognized as a putative regulatory mechanism for CYP11B2 in primary hyperaldosteronism. We aimed to investigate the DNA methylation and the expression of a panel of genes encoding several enzymes involved in steroidogenesis in adrenocortical benign tumors. We collected a total of 60 adrenocortical tissues, including 9 non-functioning adrenal adenomas, 9 adenomas associated with autonomous cortisol secretion, 17 adenomas associated with Cushing’s syndrome, 13 Conn’s adenomas and 12 tissues derived from adrenal gland adjacent to the Conn’s adenomas. Non-functioning tumors and autonomous cortisol secretion were defined according to cortisol levels after 1 mg dexamethasone suppression test ≤ or > 50 nmol/L, respectively. The DNA methylation level of CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP21A2, DHCR24, HSD3B1, HSD3B2, NR5A1, STAR, and TSPO was evaluated by quantitative Bisulfite Next Generation Sequencing (bisulfite-NGS). Bioinformatic analysis was performed in a GalaxyProject environment and processed by BSPAT (Bisulfite Sequencing Pattern Analysis Tool). Spearman correlation coefficients were calculated using IBM SPSS 21 (IBM). CYP11B1, CYP11B2, CYP17, CYP21, STAR and β-actin gene expressions were examined by quantitative Real-Time PCR using a Sybr Green Assay kit (Thermo Fisher Scientific). The equation 2−ΔΔCt was used to calculate the fold changes in gene expression between the categories of samples. CYP11B2 was significantly hypomethylated in Conn’s adenoma, when compared to other adrenal tissues (P<0.001). No difference in methylation status was found among groups for the remaining genes. CYP11B2 mRNA levels were significantly higher in Conn’s adenoma than in the remaining adrenal tissues (P=0.001). CYP21 mRNA was significantly higher in all but Conn’s adenomas, when compared to normal adrenal tissues (P<0.001). Overall, we found a negative correlation between CYP11B2 expression and DNA methylation (rho= -0.379; P=0.003). DNA methylation seems to be a pivotal regulatory mechanism for CYP11B2 expression. It is feasible that epigenetic mechanisms may be responsible for aldosterone hypersecretion in Conn’s adenoma. |
format | Online Article Text |
id | pubmed-6552772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-65527722019-06-13 SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors Di Dalmazi, Guido Morandi, Luca Rubin, Beatrice Pilon, Catia Asioli, Sofia Maffeis, Valeria Fallo, Francesco J Endocr Soc Genetics and Development (including Gene Regulation) DNA methylation has been recognized as a putative regulatory mechanism for CYP11B2 in primary hyperaldosteronism. We aimed to investigate the DNA methylation and the expression of a panel of genes encoding several enzymes involved in steroidogenesis in adrenocortical benign tumors. We collected a total of 60 adrenocortical tissues, including 9 non-functioning adrenal adenomas, 9 adenomas associated with autonomous cortisol secretion, 17 adenomas associated with Cushing’s syndrome, 13 Conn’s adenomas and 12 tissues derived from adrenal gland adjacent to the Conn’s adenomas. Non-functioning tumors and autonomous cortisol secretion were defined according to cortisol levels after 1 mg dexamethasone suppression test ≤ or > 50 nmol/L, respectively. The DNA methylation level of CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP21A2, DHCR24, HSD3B1, HSD3B2, NR5A1, STAR, and TSPO was evaluated by quantitative Bisulfite Next Generation Sequencing (bisulfite-NGS). Bioinformatic analysis was performed in a GalaxyProject environment and processed by BSPAT (Bisulfite Sequencing Pattern Analysis Tool). Spearman correlation coefficients were calculated using IBM SPSS 21 (IBM). CYP11B1, CYP11B2, CYP17, CYP21, STAR and β-actin gene expressions were examined by quantitative Real-Time PCR using a Sybr Green Assay kit (Thermo Fisher Scientific). The equation 2−ΔΔCt was used to calculate the fold changes in gene expression between the categories of samples. CYP11B2 was significantly hypomethylated in Conn’s adenoma, when compared to other adrenal tissues (P<0.001). No difference in methylation status was found among groups for the remaining genes. CYP11B2 mRNA levels were significantly higher in Conn’s adenoma than in the remaining adrenal tissues (P=0.001). CYP21 mRNA was significantly higher in all but Conn’s adenomas, when compared to normal adrenal tissues (P<0.001). Overall, we found a negative correlation between CYP11B2 expression and DNA methylation (rho= -0.379; P=0.003). DNA methylation seems to be a pivotal regulatory mechanism for CYP11B2 expression. It is feasible that epigenetic mechanisms may be responsible for aldosterone hypersecretion in Conn’s adenoma. Endocrine Society 2019-04-30 /pmc/articles/PMC6552772/ http://dx.doi.org/10.1210/js.2019-SUN-044 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Genetics and Development (including Gene Regulation) Di Dalmazi, Guido Morandi, Luca Rubin, Beatrice Pilon, Catia Asioli, Sofia Maffeis, Valeria Fallo, Francesco SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title | SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title_full | SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title_fullStr | SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title_full_unstemmed | SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title_short | SUN-044 Methylation Status and Gene Expression of Steroidogenic Enzymes in Benign Adrenocortical Tumors |
title_sort | sun-044 methylation status and gene expression of steroidogenic enzymes in benign adrenocortical tumors |
topic | Genetics and Development (including Gene Regulation) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552772/ http://dx.doi.org/10.1210/js.2019-SUN-044 |
work_keys_str_mv | AT didalmaziguido sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT morandiluca sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT rubinbeatrice sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT piloncatia sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT asiolisofia sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT maffeisvaleria sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors AT fallofrancesco sun044methylationstatusandgeneexpressionofsteroidogenicenzymesinbenignadrenocorticaltumors |